UNSPSC 51191545: Epithiazide or epitizide

This classification denotes a thiazide diuretic with the molecular formula C10H11ClF3N3O4S3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5B266B85J1, chemically known as 6-chloro-3, 4-dihydro-7-sulfamoyl-3-(2,2,2-trifluoroethylthiomethyl)-2h-1,2, 4-benzothiadiazine 1,1-dioxide but generally known as epithiazide, which bears US NIH Compound Identifier 15671. European Medicines Agency schedules Epitizide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06573MIG.

The term EPITIZIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). Epithiazide or epitizide bears US NLM identifiers UMLS ID C2700005 and NCI Concept Code C77141. SMILES: C1=C2C(=CC(=C1CL)S(=O)(=O)N)S(=O)(=O)NC(N2)CSCC(F)(F)F.

UNSPSC 51191545 Epithiazide or epitizide is a Commodity code that in recent state and local practice encompasses chemical and pharmaceutical supplies for municipal infrastructure and correctional health services. The three most recent opportunities posted under this code reveal significant scope divergence from the code's nominal pharmaceutical framing: Broward County, Florida issued a Request for Information in September 2026 for DeZurik/APCO valves, parts, and repair services for wastewater treatment compliance; the City of Meriden, Connecticut posted an invitation for bids in August 2026 for sodium bisulfite chemical supply to its Water Pollution Control Facility; and the Washington State Department of Corrections issued a Request for Quotations and Qualifications in September 2026 for parenteral products, services, and equipment (including intravenous solutions and parenteral nutrition formulations) to supply eight correctional facilities. Issuing bodies span county departments of public utilities, municipal water authorities, and state correctional agencies. The work being solicited involves procurement of specialized chemicals for water treatment operations, valve components and repair services for wastewater systems, and pharmaceutical-grade parenteral products for healthcare delivery in correctional settings.

Geographic activity concentrates in Florida, Connecticut, and Washington, with the Washington opportunity representing the largest scope by facility count and contract term (November 26, 2026 through June 30, 2030 with discretionary extension). The Broward County RFI, due September 29, 2026, seeks to determine whether DeZurik/APCO valves and repair services are available from multiple authorized suppliers or whether Controls Specialties, Inc. holds an exclusive arrangement requiring sole-source justification; vendors must demonstrate SCADA-compatible electric actuators, wastewater treatment process capability, and preventive maintenance programs. The Washington DOC RFQ, due October 7, 2026 with a pre-bid conference September 23, 2026, requires bidders to meet small business (25%), minority-owned (10%), women-owned (6%), and veteran-owned (5%) participation targets under Washington RCW Chapter 39.19; DOC anticipates awarding multiple contractors with up to three per region, pricing fixed for two years, and strict delivery windows (parenteral nutrition within 24 hours, other products within 8 hours). The Meriden bid for sodium bisulfite chemical, due July 29, 2026, specifies unit-cost evaluation and Connecticut-approved insurance carriers. All three opportunities impose performance and payment bonding or insurance requirements typical of municipal and state procurement.